He is a member of The University of Queensland Medicine and Biomedical Sciences Faculty Board, the Chairman of Griffith University’s Clinical Trials Advisory Committee and a Member of the Queensland Government’s Biofutures Industry Advisory Group. He is also a government-appointed Member of the Queensland University of Technology (QUT) Council, and associated committees.
Mario’s Non-Executive Director roles include Elo Life Systems Australia Pty Ltd, Alpine Immune Sciences Australia Pty Ltd and Suncare Community Services Ltd. Previous roles include executive positions at Sullivan Nicolaides Pathology and Mayne Group as well as serving as CEO of Life Sciences Queensland Ltd. and Queensland Clinical Trials Network Inc.
Chair of QEIF, Mark Sheridan, said “We are excited to have Mario join the QEIF Board at this stage of our development. With Mario’s experience and insight into research and clinical trials, together with his credentials as a Non-Executive Director, we are looking forward to harnessing his skills to support our sustainability and innovation strategies to achieve our purpose of saving sight.”
Here at QEI & SBDH, the health and safety of our patients and staff is of the highest priority. That's why we are taking measures to prevent the spread of COVID-19 (Coronavirus).
We kindly ask all patients and visitors of the clinic to not enter the building if they are feeling unwell (fever, cough, sore throat or flu symptoms), have been overseas in the last two weeks or have been in contact with a known case of COVID-19.
Please contact us on 07 3239 5000 to reschedule your appointment if this applies to you. Our clinic staff are taking extra precautions through the use of face masks and extra santising measures. We would like to thank all patients and visitors for their cooperation and understanding at this time.